Biogennix, LLC: payments to doctors
Reported under the Physician Payments Sunshine Act for Open Payments program years 2019–2025. Figures group every CMS reporting entity belonging to this corporate parent.
- Total reported
- $2.6M
- Providers paid
- 64
- Transactions
- 167
- Average per transaction
- $15,752
The average per transaction — $15,752 — is the number worth reading. A large total spread across hundreds of thousands of transactions is a company buying a great many modest meals at educational presentations. A large total across few transactions means consulting, speaking or royalty arrangements with a small number of physicians. The totals alone do not distinguish them.
Where the money went
| State | Total reported | Share |
|---|---|---|
| California | $2,544,409 | 96.7% |
| Texas | $49,642 | 1.9% |
| Colorado | $14,646 | 0.6% |
| Virginia | $14,575 | 0.6% |
| Iowa | $4,277 | 0.2% |
| Tennessee | $587 | 0.0% |
| Arizona | $299 | 0.0% |
| Washington | $272 | 0.0% |
| Ohio | $252 | 0.0% |
| Nebraska | $212 | 0.0% |
| Wyoming | $164 | 0.0% |
| Wisconsin | $147 | 0.0% |
| Oklahoma | $131 | 0.0% |
| Georgia | $129 | 0.0% |
| Florida | $125 | 0.0% |
| Illinois | $123 | 0.0% |
| Utah | $120 | 0.0% |
| Indiana | $113 | 0.0% |
| Montana | $105 | 0.0% |
| Minnesota | $82 | 0.0% |
| Missouri | $67 | 0.0% |
| New Mexico | $35 | 0.0% |
Products named in Biogennix, LLC's payments
The drugs and devices most often named as the product a payment related to. A meal at a presentation about a product counts here, so this tracks what the company promotes as much as what it sells.
- Morpheus$1,710,102
- Sypher$521,190
- Agilon$191,401
- DirectCell w/Agilon$179,658
- Morpheus, Agilon, DirectCell$158,975
- Morpheus, Agilon, Sypher$152,822
- Agilon Surgical Matrix$42,220
- DirectCell with Agilon Moldable$26,465
- Direct Cell w/ Agilon$16,500
- DirectCell$9,319
- DirectCell w/Agilon Moldable$2,811
- Next Generation Bone Graft$2,600
- Agilon Strip$1,826
- Agilon Strip, Agilon Moldable, DirectCell$813
- DBM Fiber$653